SCIENCE: Progress on anti-cancer vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists have synthesised a potential anti-cancer vaccine by assembling a carbohydrate molecule from chemical "building blocks".
Cells of many tumours have distinctive antigens - proteins that trigger an immune reaction - on their surfaces. It has long been known that these antigens could be used therapeutically as anti-cancer vaccines. But isolating them in usefully large quantities is difficult. Now a team from the Sloan- Kettering Institute for Cancer Research in New York believe they may have created an artificial anti-cancer vaccine. The science journal Nature, which published the research, said: "Synthetic cell-free KH-1 antigen could be used as a harmless, cell-free way to prime the immune system against tumours, in the same way that vaccination with a viral or bacterial protein fragment can protect against infectious disease."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments